Alliance Rehab - A Symbria Company Revenue and Competitors

Warrenville, IL USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Alliance Rehab - A Symbria Company's estimated annual revenue is currently $236.3M per year.(i)
  • Alliance Rehab - A Symbria Company's estimated revenue per employee is $376,794

Employee Data

  • Alliance Rehab - A Symbria Company has 627 Employees.(i)
  • Alliance Rehab - A Symbria Company grew their employee count by 15% last year.

Alliance Rehab - A Symbria Company's People

NameTitleEmail/Phone
1
Chief Human Resources OfficerReveal Email/Phone
2
CFOReveal Email/Phone
3
Chief Operating OfficerReveal Email/Phone
4
VP Symbria RehabReveal Email/Phone
5
VP Pharmacy OperationsReveal Email/Phone
6
Director Billing ServicesReveal Email/Phone
7
Regional Director OperationsReveal Email/Phone
8
Director Business DevelopmentReveal Email/Phone
9
Director Sales and MarketingReveal Email/Phone
10
Director Business DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$13.9M6036%N/AN/A
#2
$4.9M3890%N/AN/A
#3
$142.1M35710%N/AN/A
#4
$9.9M360%N/AN/A
#5
$165.7M4915%N/AN/A
#6
$607.1M16065%N/AN/A
#7
$7.8M25-11%N/AN/A
#8
$10.4M395%N/AN/A
#9
$52M1414%N/AN/A
#10
$529.2M140010%N/AN/A
Add Company

What Is Alliance Rehab - A Symbria Company?

Symbria® delivers a symbiotic approach to pharmacy, rehab and well-being services -fueled by analytics. We help the communities we partner with and the patients they serve perform at their best through the delivery of best-in-class services, resources and tools to benefit post-acute care and senior living providers. Symbria develops focused solutions for our clients’ challenges that reduce hospital readmissions, build census, and optimize length of stay.

keywords:N/A

N/A

Total Funding

627

Number of Employees

$236.3M

Revenue (est)

15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$322.1M852-2%N/A
#2
$763.9M1763-3%N/A